Role of fas apoptosis and MHC genes in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced immunotoxicity of T cells

Toxicology

Volumn 110, Issue 1-3, 1996, Pages 153-167

  Rhile, Mark J ^a   Nagarkatti, Mitzi ^b   Nagarkatti, Prakash S ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

Author keywords

Apoptosis; Fas; Immunotoxicity; MHC; TCDD; Thymus

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; FAS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNOTOXICITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; THYMUS ATROPHY;

ANIMALIA;

EID: 0029893492     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0300-483X(96)83962-X     Document Type: Article

References (34)

1. Al-Bayati, Z.A.F., Murray, W.J., Pankaskie, M.C. and Stohs, S.J. (1988) 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-induced perturbation of calcium distribution in the rat. Res. Commun. Chem. Pathol. Pharmacol. 60, 47-56.
2. Blaylock, B.L., Holladay, S.D., Comment, C.E., Heindel, J.J. and Luster, M.I. (1992) Exposure to tetrachlorodibenzo-p-dioxin (TCDD) alters fetal thymocyte maturation. Toxicol. Appl. Pharmacol. 112, 207-213.
3. Canga, L., Levi, R. and Rifkind, A.B. (1988) Heart as a target organ in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) toxicity: Decreased beta-adrenergic responsiveness and evidence of increased intracellular calcium. Proc. Natl. Acad. Sci. USA 85, 905-909.
4. Clark, G.C., Lucier, G., Luster, M.I., Thomson, M., Mahler, J. and Taylor, M. (1991) Tumor necrosis factor and dexamethasone treatment reverse acute toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicologist 11, 37.
5. Clark, G.C., Taylor, M., Tritscher, A.M. and Lucier, G.W. (1991) Tumor necrosis factor involvement in 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated endotoxin hypersensitivity in C57BL/6 mice congenic at the Ah locus. Toxicol. Appl. Pharmacol. 111, 422-431.
6. Clary, S., Nagarkatti, P.S. and Nagarkatti, M. (1990) Immunomodulatory effects of nitrosoureas on the phenotype and functions of T cells in the thymus and periphery, Immunopharmacology 20, 153-164.
7. Cook, J.C., Dold, K.M, and Greenlee, W.F. (1987) An in vitro model for studying the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin to human thymus. Toxicol. Appl. Pharmacol. 89, 256-268.
8. Dean, T., Kakkanaiah, V.N., Nagarkatti, M. and Nagarkatti, P.S. (1990) Immunosuppression by aldicarb of T cell responses to antigen-specific and polyclonal stimuli results from defective IL-1 production by the macrophages. Toxicol. Appl. Pharmacol. 106, 408-417.
9. + thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain, MRL-lpr/lpr. Proc. Natl. Acad. Sci. USA 90, 10340-10344.
10. Fine, J.S., Silverstone, A.E. and Gasiewicz, T.A. (1990) Impairment of prothymocyte activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Immunol. 144, 1169-1176.
11. Gerschenson, L.E. and Rotello, R.J. (1992) Apoptosis: A different type of cell death. FASEB J. 6, 2450-2455.
12. Greenlee, W.F., Dold, K.M., Irons, R.D., Osborne, R. (1985) Evidence for direct action of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on thymic epithelium. Toxicol. Appl. Pharmacol. 79, 112-120.
13. Hammond, D.M., Nagarkatti, P.S., Gote, L.R., Seth, A., Hassuneh, M.R. and Nagarkatti, M. (1993) Double-negative T cells from MRL-lpr/lpr mice mediate cytolytic activity when triggered through adhesion molecules and constitutively express perforin gene. J. Exp. Med. 178, 2225-2230.
14. Holladay, S.D., Lindstrom, P., Blaylock, B.L., Comment, C.E., Germolec, D.R., Heindel, J.J. and Luster, M.I. (1991) Perinatal thymocyte antigen expression and postnatal immune development altered by gestational exposure to etrachlorodibenzo-p-dioxin (TCDD). Teratology 144, 385-393.
15. Holsapple, M.P., Morris, D.L., Wood, S.C. and Snyder, N.K. (1991) 2,3,7,8-Tetrachlorodibenzo-p-dioxin induced changes in immunocompetence: Possible mechanisms. Annu. Rev. Pharmacol. Toxicol. 31, 73-100.
16. Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S., Sameshima, M., Hase, A., Seto, Y. and Nagata, S. (1991) The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66, 233-243.
17. Kakkanaiah, V.N., Pyle, R.H., Nagarkatti, M. and Nagarkatti, P.S. (1990) Evidence for major alterations in thymocyte subpopulations in murine models of autoimmune diseases. J. Autoimmunity 3, 271-288.
18. Kerkvliet, N.I., Baecher-Steppan, L., Henderson, M.C. and Buhler, D.R. (1989) Role of Ah-locus in TCDD immunotoxicity: Studies in BL/6 congenic at the Ah locus. Toxicologist 9, 39.
19. Kerkvliet, N.I. and Brauner, J.A. (1990) Flow cytometric analysis of lymphocyte subpopulations in the spleen and thymus of mice exposed to an acute immunosuppressive dose of 2,3,7,8-tetrachlorodibenzo-p-d ioxin (TCDD). Environ. Res. 52, 146-154.
20. Kerkvliet, N.I. and Oughton, J.A. (1993) Acute inflammatory response to sheep red blood cell challenge in mice treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): phenotypic and functional analysis of peritoneal exudate cells. Toxicol. Appl. Pharmacol. 119, 248-257.
21. Lawrence, D.A. (1985) Immunotoxicity of heavy metals. In: J.H. Dean, M.I. Luster, A.E., Munson and H. Amos (Eds.), Immunotoxicology and lmmunopharmacology. Raven Press, New York, p. 341-353.
22. Lundberg, K., Dencker, L. and Gronvik, K.O. (1992) 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) inhibits the activation of antigen-specific T cells in mice. Int. J. Immunopharmacol. 14, 699-705.
23. Lundberg, K., Gronvik, K.O., Goldschmidt, T.J., Klareskog, L. and Dencker, L. (1990) 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters intrathymic T cell development in mice. Chem.-Biol. Interact. 74, 179-193.
24. McConkey, D.J., Hartzell, P., Duddy, S.K., Hakansson, H. and Orrenius, S. (1988) 2,3,7,8-Tetrachlorodibenzo-p-dioxin kills immature thymocytes by calcium mediated endonuclease activation. Science 242, 256-259.
25. McKallip, R.J., Nagarkatti, M. and Nagarkatti, P.S. (1995) Immunotoxicity of AZT: inhibitory effect on thymocyte differentiation and peripheral T cell responsiveness to gp120 of HIV. Toxicol. Appl. Pharmacol. 131, 53-62.
26. Nagarkatti, P.S., Sweeney, G.D., Gauldie, J. and Clark, D.A. (1984) Sensitivity to suppression of cytotoxic T cell generation by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is dependent on the phenotype of the murine host. Toxicol. Appl. Pharmacol. 72, 169-176.
27. Oehm, A., Behermann, I., Falk, W., Pawlita, M., Maier, G., Klas, C., Li-Weber, M., Richards, S., Dhein, S., Trauth, B.C., Bonsting, H. and Krammer, P. (1992) Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. J. Biol. Chem. 269, 10709-10715.
28. Okey, A.B., Mason, M.E. and Vella, L.M. The Ah receptor species and tissue variation in binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin and carcinogenic aromatic hydrocarbons in extrahepatic drug metabolism and chemical carcinogenesis. In: J. Rydstrom, J. Montelius and M. Bengtsson (Eds.), Elsevier, Amsterdam, p. 389-399.
29. Puhvel, S.M. and Sakamoto, M. (1989) Increase in epidermal Langerhans cells in mouse skin following treatment with TCDD. Chemosphere 18, 253-257.
30. Safe, S.H. (1986) Comparative toxicology and mechanisms of action of polychlorinated dibenzo-p-dioxins and dibenzofurans. Annu. Rev. Pharmacol. Toxicol. 26, 371-399.
31. Seth, A., Pyle, R.H., Nagarkatti, M. and Nagarkatti, P.S. (1988) Expression of J11-d marker on peripheral T lymphocytes of MRL-lpr/lpr mice. J. Immunol. 141, 1120-1125.
32. Silkworth, J.B. and Grabstein, E.M. (1982) Polychlorinated biphenyl immunotoxicity: dependence on isomer planarity and the Ah gene complex. Toxicol. Appl. Pharmacol. 65, 109-115.
33. Silverstone, A.J., Frazier, D.E., Fiore, N.C., Soults, J.A. and Gasiewicz, T.A. (1994) Dexamethasone, beta-estradiol, and 2,3,7,8-tetrachlorodibenzo-p-dioxin elicit thymic atrophy through different cellular targets. Toxicol. Appl. Pharmacol. 126, 248-259.
34. Watanabe-Fukunaga, R., Brannan, C.I., Copeland, N.G., Jenkins, N.A. and Nagata, S. (1992) Lymphoproliferation disorder in man explained by defects in Fas antigen. Nature 356, 314-317.